Literature DB >> 18574212

Menstrual health and the metabolic syndrome in adolescents.

Hala Tfayli1, Silva Arslanian.   

Abstract

The metabolic syndrome, a constellation of interrelated risk factors for cardiovascular disease and type 2 diabetes mellitus, has become a major public health concern against the backdrop of increasing rates of obesity. Insulin resistance plays a pivotal role as the underlying pathophysiological linchpin of the various components of the syndrome. The metabolic syndrome is well recognized in adults, and there is convincing evidence that it starts in childhood, with progressive clustering of the various components over time and tracking through adulthood. Adult women and adolescents with polycystic ovary syndrome (PCOS) have higher prevalence rates of the metabolic syndrome compared with the general population. Several anthropometric (obesity, particularly abdominal obesity), metabolic (insulin resistance/hyperinsulinemia, dyslipidemia) and hormonal (low IGFBP1, IGFBP2 and low sex hormone binding globulin) features of adolescents with PCOS are also features of the metabolic syndrome. Insulin resistance, believed to be a key pathogenic factor in both PCOS and the metabolic syndrome, may be the thread that links the two conditions. Menstrual health in adolescents could be viewed as yet another component in the evaluation of the metabolic syndrome. Careful assessment of menstrual history and appropriate laboratory work-up could reveal the presence of PCOS in obese at-risk adolescent girls with a family history of the metabolic syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18574212      PMCID: PMC2723764          DOI: 10.1196/annals.1429.024

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  70 in total

1.  Metabolic syndrome: is it a syndrome? Does it matter?

Authors:  Richard Kahn
Journal:  Circulation       Date:  2007-04-03       Impact factor: 29.690

2.  Polycystic ovary syndrome: androgens and hypertension.

Authors:  Jane F Reckelhoff
Journal:  Hypertension       Date:  2007-03-26       Impact factor: 10.190

3.  Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.

Authors:  Robin J Bell; Sonia L Davison; Mary-Anne Papalia; Dean P McKenzie; Susan R Davis
Journal:  Menopause       Date:  2007 Jul-Aug       Impact factor: 2.953

4.  The metabolic syndrome in children and adolescents.

Authors:  Paul Zimmet; George Alberti; Francine Kaufman; Naoko Tajima; Martin Silink; Silva Arslanian; Gary Wong; Peter Bennett; Jonathan Shaw; Sonia Caprio
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

5.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

Review 6.  Polycystic ovary syndrome: a risk for coronary artery disease?

Authors:  Robert A Wild
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

7.  Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

Authors:  Mei-Jou Chen; Wei-Shiung Yang; Jehn-Hsiahn Yang; Chi-Ling Chen; Hong-Nerng Ho; Yu-Shih Yang
Journal:  Hypertension       Date:  2007-03-26       Impact factor: 10.190

8.  Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.

Authors:  Silva A Arslanian; Vered Lewy; Kapriel Danadian; Rola Saad
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

9.  Altered vascular function in young women with polycystic ovary syndrome.

Authors:  Christopher J G Kelly; Angela Speirs; Gwyn W Gould; John R Petrie; Helen Lyall; John M C Connell
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

Review 10.  Metabolic syndrome, or What you will: definitions and epidemiology.

Authors:  Caroline Day
Journal:  Diab Vasc Dis Res       Date:  2007-03       Impact factor: 3.291

View more
  10 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 2.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

3.  Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

Authors:  Hala Tfayli; Julia Warren Ulnach; SoJung Lee; Kim Sutton-Tyrrell; Silva Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

4.  Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study.

Authors:  John A Morrison; Charles J Glueck; Stephen R Daniels; Paul S Horn; Ping Wang
Journal:  Metabolism       Date:  2012-04-16       Impact factor: 8.694

Review 5.  Obesity and the pubertal transition in girls and boys.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Reproduction       Date:  2010-09       Impact factor: 3.906

6.  Long menstrual cycle is associated with type 2 diabetes mellitus in korean women.

Authors:  Unjin Shim; Jee-Young Oh; Hye Jin Lee; Young Sun Hong; Yeon-Ah Sung
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

7.  Testosterone and metabolic syndrome: The link.

Authors:  Ranabir Salam; Achouba Singh Kshetrimayum; Reetu Keisam
Journal:  Indian J Endocrinol Metab       Date:  2012-03

8.  The effects of obesity on the menstrual cycle.

Authors:  Khalida Itriyeva
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2022-07-21

Review 9.  Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue.

Authors:  Wagner Silva Dantas; Bruno Gualano; Michele Patrocínio Rocha; Cristiano Roberto Grimaldi Barcellos; Viviane dos Reis Vieira Yance; José Antonio Miguel Marcondes
Journal:  ScientificWorldJournal       Date:  2013-06-05

Review 10.  Poly Cystic Ovarian Syndrome: An Updated Overview.

Authors:  Samer El Hayek; Lynn Bitar; Layal H Hamdar; Fadi G Mirza; Georges Daoud
Journal:  Front Physiol       Date:  2016-04-05       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.